Bella Ertik

1.3k citations
7 papers · 930 indexed · 1 hit paper · h-index 5
Topics
Multiple Sclerosis Research Studies (3 papers)Immunodeficiency and Autoimmune Disorders (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)

In The Last Decade

Bella Ertik

7 papers receiving 911 citations

Hit Papers

Alemtuzumab versus interferon beta 1a as first-line treat...20122026201620212012250500750

Peers

Bella Ertik
Comparison fields: 5 of 65
  • Pathology and Forensic Medicine 756
  • Neurology 286
  • Oncology 272
  • Immunology 248
  • Rheumatology 236
Replace Tamara Miller with:
Tamara Miller United States
M. Stojanovic Serbia
Pedro Oyuela United States
Karthinathan Thangavelu United States
Florence Casset‐Semanaz Switzerland
Hayato Yamazaki Japan
Timon Bogumil Germany
Teresa Bagulho United States
J. Woody Germany
P. Gjörstrup Sweden
Bella Ertik relative to Tamara Miller United States Tamara Miller's profile →
Citations per field
00.5×1.5×
Tamara Miller · 1×
Citations per year

Countries citing papers authored by Bella Ertik

Since Specialization
Citations

This map shows the geographic impact of Bella Ertik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bella Ertik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bella Ertik more than expected).

Fields of papers citing papers by Bella Ertik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bella Ertik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bella Ertik. The network helps show where Bella Ertik may publish in the future.

Co-authorship network of co-authors of Bella Ertik

This figure shows the co-authorship network connecting the top 25 collaborators of Bella Ertik. A scholar is included among the top collaborators of Bella Ertik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bella Ertik. Bella Ertik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 26
2 4
3 9
4 1
5 5
6 2
7
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialbreakdown →
883

About Bella Ertik

Bella Ertik is a scholar working on Pathology and Forensic Medicine, Immunology and Nephrology, having authored 7 papers that have together received 930 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (756 citations), Neurology (286 citations) and Rheumatology (236 citations). Bella Ertik has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jeffrey Cohen, Edward Fox, Douglas L. Arnold, Eva Havrdová, David Margolin, Alasdair Coles, Michael Panzara, D. A. S. Compston, Krzysztof Selmaj and Hans-Peter Hartung. Their work appears in journals such as The Lancet, Neurology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026